HER2/Neu Positive Active Not Recruiting Phase 3 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0037939 (HER2/Neu Positive)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00770809Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by SurgeryTreatment
NCT00785291Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast CancerTreatment
NCT01196390Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal CancerTreatment
NCT01275677Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerTreatment